This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Tue May 21, 2013 11:11 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 2 posts ] 
Author Message
PostPosted: Fri Nov 30, 2012 3:08 pm 
Offline
Family Elder

Joined: Mon Jan 04, 2010 4:00 pm
Posts: 8506
http://www.ncbi.nlm.nih.gov/pubmed/23151461

Quote:
Physiol Meas. 2012 Dec;33(12):2033-48. doi: 10.1088/0967-3334/33/12/2033. Epub 2012 Nov 15.
A wireless body measurement system to study fatigue in multiple sclerosis.
Yu F, Bilberg A, Stenager E, Rabotti C, Zhang B, Mischi M.

Mads Clausen Institute, University of Southern Denmark, Alsion 2, Sønderborg, DK-6400, Denmark.

Abstract
Fatigue is reported as the most common symptom by patients with multiple sclerosis (MS). The physiological and functional parameters related to fatigue in MS patients are currently not well established. A new wearable wireless body measurement system, named Fatigue Monitoring System (FAMOS), was developed to study fatigue in MS. It can continuously measure electrocardiogram, body-skin temperature, electromyogram and motions of feet. The goal of this study is to test the ability of distinguishing fatigued MS patients from healthy subjects by the use of FAMOS. This paper presents the realization of the measurement system including the design of both hardware and dedicated signal processing algorithms. Twenty-six participants including 17 MS patients with fatigue and 9 sex- and age-matched healthy controls were included in the study for continuous 24 h monitoring. The preliminary results show significant differences between fatigued MS patients and healthy controls. In conclusion, the FAMOS enables continuous data acquisition and estimation of multiple physiological and functional parameters. It provides a new, flexible and objective approach to study fatigue in MS, which can distinguish between fatigued MS patients and healthy controls. The usability and reliability of the FAMOS should however be further improved and validated through larger clinical trials.


A way to objectively measure fatigue could demonstrate improvements in fatigue seen after the CCSVI procedure.


Top
 Profile  
 
PostPosted: Fri Nov 30, 2012 4:23 pm 
Offline
Family Elder
User avatar

Joined: Fri Apr 01, 2011 3:00 pm
Posts: 305
Location: Canada
Quote:
It can continuously measure electrocardiogram, body-skin temperature, electromyogram and motions of feet.


This information will be very interesting to see as well and to see how they utilize the data beyond fatigue.


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 2 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. OCT should be a measurement in CCSVI trials

Cece

0

282

Wed Oct 03, 2012 8:27 am

Cece View the latest post

There are no new unread posts for this topic. Anyone have MRI post-CCSVI tx or objective improvement?

hope410

1

1045

Tue Apr 06, 2010 7:02 am

cathyb View the latest post

There are no new unread posts for this topic. measurement of azygous blood flow

Cece

5

828

Thu Jul 21, 2011 4:20 pm

Johnson View the latest post

There are no new unread posts for this topic. Non-invasive measurement of Azygous vein bloodflow...

ikulo

2

1174

Mon May 17, 2010 11:47 am

hwebb View the latest post

There are no new unread posts for this topic. Finally objective test results pre and post venoplasty-fMRI

MegansMom

5

931

Wed Jun 15, 2011 8:15 am

Cece View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: